One has to ask wether the market got it right at $2 or right at 2.5c......Same company only 12 months apart.If the market was always right, you wouldn't have anything to trade.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%